Thank you, Koid. I'm pleased to announce the launch of Flotek's line of FDA quality sanitizers and disinfectants for industrial and personal consumer applications. Our initial efforts were cultivated as a result of community outreach that began in the first quarter when we started producing it donating sanitizer to local communities, first responders, hospitals, schools, homeless shelters, and senior residential communities. Subsequently, we recognized the opportunity to diversify our revenue stream into a rejuvenated high-growth potential market, which is a natural extension of our Specialty Chemistry experience. This enabled us to leverage our chemical production capabilities and maximize utilization of our existing facilities. Thus, in Q2 we launched and are actively selling FDA registered sanitizer products into multiple markets, including hospitals and medical facilities, the travel and hospitality industry, food services, e-commerce and retail, sports entertainment, and other industrial and consumer markets. In order to develop this business, we applied our existing competitive advantages of innovating and delivering differentiated chemistries, our ISO certified manufacturing capabilities, our strong supply chain management, efficient production capacity, and an R&D footprint that is highly respected in energy and chemistry business. Applying our technical abilities in R&D skills, we're able to offer high quality FDA registered products. And as you know, more than 100 hand sanitizers are being pulled from the market due to regulatory violations at the FDA's Directive. Quality is more important than ever if you want to be a long-term major player in this market. Flotek offers, high-quality American made products to stand out in the marketplace, the active components that make up our sanitizer our pharmaceutical grade and are sourced here in the United States. Our liquid and gel products are formulated in Houston and blended in our facilities in Texas and Oklahoma. Given the flexibility of our business model, we've been able to quickly pivot our manufacturing operations by leveraging the exact same chemistry and facilities we already utilized in the energy chemistry technology business, thereby minimizing the need for entry-level capital investment for such a large potential, revenue opportunity. Our sanitizer initiative exemplifies how we are adapting and reallocating resources to businesses that will drive greater returns given its low-cost, high-margin profile. And our current assets have total blending capacity of 2.1 million gallons of specialty chemistries on a monthly basis, which includes both energy chemistry technologies and sanitizer product lines. Furthermore, the hand sanitizer market was nearly $3 billion in 2019. And all other markets had stalled growth of 1400% from December of 2019 to February of 2020 due to COVID pandemic demand, market experts still anticipate healthy market growth rates in excess of 7% even in a post COVID world, and we look forward to providing additional updates as we expand our sales in this exciting new market. Now, I'll turn it back to John.